Troy A. Ignelzi, Chief Financial Officer at Karuna Therapeutics, Inc. (KRTX), sold 4,948 shares at $133.20 ($651K) on 2022-04-20, disclosed to the SEC on 2022-04-21.
Open-market sale of $651k KRTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $130.81 | 3,500 | $458K | 70.4% |
| 2 | $133.20 | 704 | $94K | 14.4% |
| 3 | $133.20 | 704 | $94K | 14.4% |
| 4 | $134.46 | 40 | $5K | 0.8% |
| Total | $131.52 avg | 4,948 | $651K | 100% |
| Filing → |
| KRTX | SELL | 2023-05-25 | $4.0M | — | Filing → |
| KRTX | SELL | 2023-02-23 | $1.1M | — | Filing → |
| KRTX | SELL | 2023-01-19 | $369K | — | Filing → |